Allergy Therapeutics: Hypersensitivity trials

The registry lists 19 Hypersensitivity studies with Allergy Therapeutics as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 1 5Phase 2 10Phase 3 2No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• GRASS (Grass MATA MPL Real-world Assessment Study)RecruitingNCT07412990
• Tyrosine Allergoid Paediatric and Adult StudyActive, not recruitingNCT05186025
• Efficacy and Safety/Tolerability of Ragweed MATA MPLCompletedNCT00423787Phase 3
• Efficacy and Safety/Tolerability of Grass MATA MPLCompletedNCT00414141Phase 3
• Investigation of Efficacy and Safety of Tree MATAMPL,Tree MATA, and Placebo in Patients With Birch-Induced Seasonal Allergic RhinitisTerminatedNCT00387478Phase 2
• Follow-up Investigation of Efficacy of Ragweed MATAMPL,and Placebo in Patients With Ragweed-induced Seasonal Allergic RhinitisCompletedNCT00325338Phase 2
• Investigation of Safety+Efficacy of Different Doses of RagweedMATAMPL;Assessment of Residual Allergenicity Using Skin Prick TestCompletedNCT00258635Phase 2
• Safety, Immunological Effect and Efficacy of the Combined Application of MPL and Grass Pollen AllergenCompletedNCT00241410Phase 1
• Different Doses of Tyrosine Adsorbed Grass Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Grass PollenCompletedNCT00133159Phase 2
• Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Grass Pollen Allergy VaccineCompletedNCT00133146Phase 2
• Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Tree Pollen Allergy VaccineCompletedNCT00118625Phase 2
• Different Doses of Tyrosine Adsorbed Tree Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Tree PollenCompletedNCT00118612Phase 2
• Assessment of Residual Allergenicity of Ragweed Pollen Allergoid With Monophosphoryl Lipid A (MPL) Using Skin Prick TestingCompletedNCT00116285Phase 1
• Induction of Immunogenicity With Different Doses of TreeMATA in Subjects Allergic to Tree PollenCompletedNCT00113750Phase 2
• Investigation of Efficacy and Safety of Ragweed MATAMPL, Pollinex-R and Placebo in Patients With Ragweed AllergyCompletedNCT00110786Phase 2
• Evaluation of Safety and Tolerability of Tyrosine Adsorbed Ragweed Pollen Allergoid With MPL (Monophosphoryl Lipid A)WithdrawnNCT00109759Phase 1
• Assessment of Residual Allergenicity of Tree (Birch, Hazel, and Alder) Pollen Allergoid Using Skin Prick TestingCompletedNCT00107705Phase 1
• Assessment of Residual Allergenicity of Grass/Rye Pollen Allergoid Using Skin Prick TestingCompletedNCT00104390Phase 1
• Induction of Immunogenicity With Different Doses of Grass MATA in Subjects Allergic to Grass and Rye PollenCompletedNCT00104377Phase 2